相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
P. Lenzini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial
Jungnam Joo et al.
CLINICAL TRIALS (2010)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A flexible strategy for testing subgroups and overall population
Mohamed Alosh et al.
STATISTICS IN MEDICINE (2009)
The Use of Genomics in Clinical Trial Design
Richard Simon
CLINICAL CANCER RESEARCH (2008)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans
H. Schelleman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature
G. Dolan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients
P. A. Lenzini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation:: A prospective randomized controlled study
Y. Caraco et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
Sue-Jane Wang et al.
PHARMACEUTICAL STATISTICS (2007)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Warfarin maintenance dosing patterns in clinical practice - Implications for safer anticoagulation in the elderly population
D Garcia et al.
CHEST (2005)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients:: A HuGEnet™ systematic review and meta-analysis
S Sanderson et al.
GENETICS IN MEDICINE (2005)
Evaluating the efficiency of targeted designs for randomized clinical trials
R Simon et al.
CLINICAL CANCER RESEARCH (2004)
Trials within trials:: Confirmatory subgroup analyses in controlled clinical experiments
LA Moyé et al.
CONTROLLED CLINICAL TRIALS (2001)